Andrew McIntosh
speaker
180 appearances
2 recordings
2 series
first heard Mar 2025
last heard 1 May
Andrew McIntosh’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in May 2026 with 1.
Appearances
But absolutely not seven.
Because I was waiting and I had an aggressive cancer, the haematology team needed to find a regimen of drugs to put me on to keep the cancer at bay.
And they used daraturamib, which is a drug that is used for other cancers, not normally used for my one.
But they thought that it might be a good option to keep the cancer at bay because it was lower impact than normal chemotherapy.
When they applied to get that drug for me, they had to submit evidence of how well it works.
And so they asked their overseas colleagues if anyone had tried doing this with this particular drug before.
And the overseas colleagues came back and told them
no, we don't ever let someone wait when they've got a cancer like that.
So there was no international advice.
The local team had to do things off their own bat and that's the path that we walked.
So sourcing the stem cells from the donor was not part of what was stopping me moving ahead.
It was capacity.
Bone marrow transplant or stem cell transplant is a really intensive, full-on process.
You need to be in an isolation room.
You need a lot of care.
You have no immune system and you're not producing any of your own blood cells for the whole time you're going through that process.
And so there is limited capacity.
And that includes the staff, both haematologists and nurses, but also beds on the wards in these isolation rooms.
It's a very resource intensive process.
And then just as I was actually getting ready for my transplant and I had a few tests done to see that I was still in remission and ready to get the transplant, we found that the cancer had actually returned and that I'd relapsed.
Showing 41–60 of 180 · page 3 of 9
← Previous
Next →